Treatment of Acne Fulminans
Start prednisone 0.5-1 mg/kg/day immediately upon diagnosis of acne fulminans, then add low-dose isotretinoin (0.5 mg/kg/day or lower) at week 4, slowly tapering the prednisone over several months while continuing isotretinoin to achieve a cumulative dose of 120-150 mg/kg. 1
Initial Management: Systemic Corticosteroids First
The cornerstone of acne fulminans treatment is immediate initiation of oral prednisone at 0.5-1 mg/kg/day to control both the systemic manifestations (fever, arthralgia, elevated inflammatory markers) and the explosive cutaneous eruption 1. This approach is critical because acne fulminans represents a severe inflammatory process that will not respond to traditional acne therapies alone.
Key timing considerations:
- Systemic corticosteroids should be started immediately upon diagnosis—do not delay 2
- Earlier steroid initiation leads to faster control of both systemic features and skin lesions 2
- The typical starting dose is prednisone 30 mg/day (divided as 10-10-10) for patients, which can be adjusted based on weight 3
Adding Isotretinoin: The Critical Delay
Do not start isotretinoin immediately. Instead, wait approximately 4 weeks after initiating prednisone before introducing isotretinoin 2. This delay is essential because:
- Starting isotretinoin too early or at standard doses can precipitate or worsen acne fulminans 1
- The initial inflammatory burden must be controlled with corticosteroids first
- When isotretinoin is added, start at a very low dose of 0.5 mg/kg/day or even lower (0.25 mg/kg/day in extremely severe cases) 1, 3
The evidence strongly supports this sequential approach: a retrospective analysis of 25 patients over 25 years demonstrated that protocols combining prednisolone with delayed isotretinoin led to faster control of systemic features and acne clearance compared to antibiotics alone or steroids without isotretinoin 2.
The Steroid Taper: A Slow Process
Plan for a slow taper over several months while transitioning to isotretinoin or oral antibiotics 1. The typical protocol:
- Maintain prednisone at initial dose for 4-6 weeks 2
- Begin gradual taper only after systemic symptoms resolve and skin lesions show significant improvement (>50% improvement typically seen at 1 month) 3
- Continue tapering slowly over 2-3 months to minimize relapse risk 1
- Do not rush the taper—relapses are common with premature steroid discontinuation
Isotretinoin Dosing Strategy
Once isotretinoin is introduced at week 4:
- Start at 0.5 mg/kg/day (can split as 0.25-0-0.25 to reduce adverse effects) 3
- In extremely severe cases, consider even lower starting doses (0.25 mg/kg/day) 1
- Gradually increase as tolerated, but do not rush to standard 1 mg/kg/day dosing
- Target cumulative dose of 120-150 mg/kg for optimal long-term outcomes 1
- Total treatment duration should be at least 3-5 months to avoid relapses 4
Adjunctive Antibiotics: Limited Role
While oral antibiotics (particularly tetracyclines like doxycycline) have been used historically, the evidence shows they produce a slow response compared to the corticosteroid-isotretinoin combination 2. Antibiotics may be considered as:
- A bridge therapy during the first 4 weeks while waiting to start isotretinoin
- An alternative if isotretinoin cannot be used, though outcomes are inferior 2
- The 2016 AAD guidelines specifically indicate prednisone is for "treatment and prevention of isotretinoin-induced acne fulminans-like eruptions," not antibiotics as primary therapy 1
Second-Line and Rescue Therapies
When the standard prednisone-isotretinoin regimen fails (which occurs in approximately 8-33% of cases based on recent data):
TNF-α inhibitors represent the most promising second-line option:
- Adalimumab is the most commonly used 5
- Clinical response typically seen within 1 month in 42-67% of cases 5
- Treatment success achieved in 67-92% after median 3-7 months 5
- Adverse effects are generally mild and reversible 5
Other alternatives reported in case series include:
- Dapsone
- Cyclosporine A
- Methotrexate
- Azathioprine
- Anakinra (IL-1 inhibitor)
- Infliximab 6
However, these lack robust evidence and should be reserved for truly refractory cases in consultation with specialists.
Critical Pitfalls to Avoid
Starting isotretinoin without corticosteroids or at standard doses: This is the most common error and can precipitate or worsen acne fulminans 1, 7
Tapering prednisone too quickly: Rapid taper leads to relapses—plan for months, not weeks 1, 2
Treating as standard severe acne: Traditional acne therapies (topical agents, antibiotics alone) are ineffective and delay appropriate treatment 2, 4
Inadequate isotretinoin cumulative dose: Stopping too early increases relapse risk—target 120-150 mg/kg 1
Missing the diagnosis in isotretinoin-treated patients: 57% of acne fulminans cases occur after isotretinoin initiation, typically within 45 days 7
Monitoring During Treatment
- Week 1-4: Monitor for resolution of fever, arthralgia, and systemic symptoms (should resolve within 1 month) 3
- Month 1: Expect >50% improvement in skin lesions in approximately 65% of patients 3
- Ongoing: Standard isotretinoin monitoring (LFTs, lipids at baseline and periodically; CBC not routinely needed) 1
- Long-term: All patients develop scarring—early intervention and consideration of scar management is essential 3, 8
Special Considerations
Isotretinoin-associated acne fulminans: When AF develops during isotretinoin therapy, immediately discontinue or reduce isotretinoin, start prednisone, then cautiously reintroduce isotretinoin at very low doses after 4 weeks 8, 7. The evidence shows no distinct clinical characteristics differentiating isotretinoin-associated from spontaneous AF, but management requires more caution with isotretinoin reintroduction 7.
Duration of therapy: Treatment should not be less than 3-5 months total to minimize relapse risk 4. The prednisone taper alone typically takes 2-3 months, with isotretinoin continuing beyond that point.